Abstract
Psychiatric disorders are highly heterogeneous, and it is clinically meaningful to distinguish psychiatric disorders by the presence or absence of a specific comorbid condition. In this study, we employed a recently developed algorithm (CombGWAS) to decipher the genetic basis of psychiatric disorder combinations. The focus was on comorbidities and combinations of disorders, such as major depressive disorder(MDD) with and without schizophrenia(SCZ), which can be considered as two ‘subtypes’ of MDD. We also studied psychiatric disorders comorbid with obesity as disease subtypes.
Our study identified genetic variants associated with different “subtypes” and the genetic architecture underlying the 16 psychiatric disorder combinations. We also performed further analysis including gene-based (MAGMA), tissue specificity, and pathway enrichment analyses. Genetic correlation and Mendelian randomization(MR) analysis were also performed across different psychiatric disorder “subtypes”, and with various cardiovascular diseases(CVD).
We identified 653 risk loci associated with the 16 psychiatric disorder entities. While high genetic correlations(rg) were observed between many subtypes, MDD with and without obesity only showed modest genetic correlation(rg=0.166). Interestingly, most subtype pairs exhibited distinct genetic correlations with the same cardiovascular disease. Some pairs even displayed opposite genetic correlations. For instance, the genetic correlation(rg) between SCZ with obesity and type 2 diabetes(T2DM) was 0.248(p=4.42E-28), while rg between SCZ without obesity and T2DM was -0.154(p=6.79E-12). Using MR, we observed that many psychiatric comorbidities may be causally linked to increased CVD risks, but the effect size differed substantially. Comorbid psychiatric disorders typically display different causal effects with CVD compared to single psychiatric disorders without comorbidities. This study represents a significant step toward unravelling the heterogeneity underlying psychiatric disease combinations and comorbidities, shedding light on their underlying pathophysiology.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded partially by a National Natural Science Foundation China (NSFC) Young Scientist Grant (31900495), a National Natural Science Foundation China grant (81971706), the Lo Kwee Seong Biomedical Research Fund from The Chinese University of Hong Kong and the KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Kunming Institute of Zoology and The Chinese University of Hong Kong, China.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All GWAS summary statistics used in this study were publicly available at PGC, iPSYCH,CTG and GIANT consortium
